GL1X · GenesisL1 explorer

Research workbench

Human DNA polymerase mu- apoenzyme

Analyse Human DNA polymerase mu- apoenzyme in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4LZD
Type
protein
Length
335 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
DNA-directed DNA/RNA polymerase mu
EC
2.7.7.7
UniProt
Q9NP87
Ligands
NA, CL
Pockets
1 · best druggability 0.58

Structure

x-ray diffraction · 1 distinct chain · 51% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADNA-directed DNA/RNA polymerase mu (EC 2.7.7.7)protein33551% helix, 16% strandQ9NP87

Ligands and binding sites

  • NA · Sodium ion · metal · chains A
  • CL · Chloride ion · ion · chains A
  • IMD · Imidazole · additive · chains A
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15110.580.7359CL

Compared structures

  • 4LZD · Human DNA polymerase mu- Apoenzyme · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9NP87 · AlphaFold monomer V2.0 prediction for DNA-directed DNA/RNA polymerase mu (Q9NP87) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.